Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1668553-26-1

Post Buying Request

1668553-26-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1668553-26-1 Usage

Description

A-1210477 is an inhibitor of the antiapoptotic Bcl-2 family protein myeloid cell leukemia-1 (Mcl-1), which plays a crucial role in preventing programmed cell death. With a Ki value of 0.43 nM and an IC50 value of 26.2 nM, A-1210477 exhibits over 100-fold selectivity for Mcl-1 compared to other Bcl-2 family members. A-1210477 has been demonstrated to disrupt the interaction between Mcl-1 and pro-apoptotic BIM, leading to the induction of apoptosis in Mcl-1-dependent multiple myeloma and non-small cell lung cancer cell lines.

Uses

Used in Oncology:
A-1210477 is used as an anticancer agent for targeting Mcl-1, an anti-apoptotic protein that is overexpressed in various cancers. By inhibiting Mcl-1, A-1210477 promotes apoptosis in cancer cells, particularly in multiple myeloma and non-small cell lung cancer cell lines. This selective inhibition of Mcl-1 can potentially enhance the effectiveness of cancer treatments and improve patient outcomes.
Used in Drug Development:
A-1210477 is used as a lead compound in the development of novel therapeutics for cancer treatment. Its high selectivity for Mcl-1 makes it a valuable starting point for designing new drugs that can target this protein with minimal off-target effects. This could lead to the development of more effective and safer cancer treatments.
Used in Research:
A-1210477 is used as a research tool for studying the role of Mcl-1 in apoptosis and cancer cell survival. Its ability to selectively inhibit Mcl-1 makes it a valuable compound for investigating the molecular mechanisms underlying cell death and the development of resistance to cancer therapies. This can help researchers better understand the biology of cancer and identify new targets for therapeutic intervention.

references

[1]. lopez j, bessou m, riley js, et al. mito-priming as a method to engineer bcl-2 addiction. nature communications, 2016, 7:10538.[2]. besbes s, mirshahi m, pocard m, et al. new dimension in therapeutic targeting of bcl-2 family proteins. oncotarget, 2015, 6(15): 12862.[3]. leverson jd, zhang h, chen j, et al. potent and selective small-molecule mcl-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with abt-263 (navitoclax). cell death & disease, 2015, 6(1): e1590.[4]. mott jl, kobayashi s, bronk sf, et al. mir-29 regulates mcl-1 protein expression and apoptosis. oncogene, 2007, 26(42): 6133-6140.[5]. opferman jt. attacking cancer's achilles heel: antagonism of anti-apoptotic bcl-2 family members. febs journal, 2015.

Check Digit Verification of cas no

The CAS Registry Mumber 1668553-26-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,6,8,5,5 and 3 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1668553-26:
(9*1)+(8*6)+(7*6)+(6*8)+(5*5)+(4*5)+(3*3)+(2*2)+(1*6)=211
211 % 10 = 1
So 1668553-26-1 is a valid CAS Registry Number.

1668553-26-1Upstream product

1668553-26-1Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1668553-26-1